Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1999-08-04
Original market date: See footnote 1
1994-12-31
Product name:
TRANSDERM-NITRO 0.8
DIN:
02046164 Electronic product monograph is not available
Company:
NOVARTIS PHARMACEUTICALS CANADA INC
100
700 Rue Saint-Hubert
Montreal
Quebec
Canada
H2Y 0C1
Class:
Human
Dosage form(s):
Patch (Extended Release)
Route(s) of administration:
Transdermal
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
24:12.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
C01DA02 GLYCERYL TRINITRATE
Active ingredient group (AIG) number:See footnote5
0103615012
Active ingredient(s) | Strength |
---|---|
NITROGLYCERIN | 100 MG / SRD |